Abiopharma

🔍 Lalomia Brent (Executive)

Company: CONMED Corp (CNMD)

Report Date: 2026-03-06

Detailed Transactions and Holdings:

• Acquired 75 shares of Common Stock (Direct)
  Date: 2026-03-06 | Code: M | equity_swap_involved: 0 | shares_owned_after: 941.06 | transaction_form_type: 4 | Footnotes: F1
• Sold 26 shares of Common Stock at $39.9 per share (Direct)
  Date: 2026-03-06 | Code: F | equity_swap_involved: 0 | shares_owned_after: 915.06 | transaction_form_type: 4
• Sold 75 shares of RSUs (Restricted Stock Units) (Derivative)
  Date: 2026-03-06 | Code: M | Expires: 2032-03-07 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F2

Footnotes:

• F1: The number of shares beneficially owned by the reporting person has been adjusted to exclude 140 shares that were incorrectly reflected in prior reports.
• F2: Represents the settlement of vested restricted stock units (RSUs) with the delivery of shares of common stock, subject to withholding for taxes. Each RSU represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation.